These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18813126)

  • 1. Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis.
    Warren M; Twohig M; Pier T; Eickhoff J; Lin CY; Jarrard D; Huang W
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):23-30. PubMed ID: 18813126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the matriptase inhibitor HAI-2 during prostate cancer progression.
    Bergum C; List K
    Prostate; 2010 Sep; 70(13):1422-8. PubMed ID: 20687215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
    Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
    Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
    Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
    Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.
    Zeng L; Cao J; Zhang X
    World J Gastroenterol; 2005 Oct; 11(39):6202-7. PubMed ID: 16273651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
    Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
    Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepatocyte growth factor activator inhibitor-1 (HAI-1) gene in prostate cancer: clinical and biological significance.
    Hu C; Jiang N; Wang G; Zheng J; Yang W; Yang J
    J BUON; 2014; 19(1):215-20. PubMed ID: 24659667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Hepatocyte growth factor activator inhibitor type-1 (HAI-1) in prostate cancer.
    Yasuda K; Komiya A; Watanabe A; Morii A; Oya T; Nagakawa O; Fujiuchi Y; Fuse H
    Anticancer Res; 2013 Feb; 33(2):575-81. PubMed ID: 23393351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
    Vogel LK; Saebø M; Skjelbred CF; Abell K; Pedersen ED; Vogel U; Kure EH
    BMC Cancer; 2006 Jul; 6():176. PubMed ID: 16820046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.
    Tsai CH; Teng CH; Tu YT; Cheng TS; Wu SR; Ko CJ; Shyu HY; Lan SW; Huang HP; Tzeng SF; Johnson MD; Lin CY; Hsiao PW; Lee MS
    Oncogene; 2014 Sep; 33(38):4643-52. PubMed ID: 24121274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro.
    Sanders AJ; Parr C; Mason MD; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):613-9. PubMed ID: 17786295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
    Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.
    Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells.
    Kiyomiya K; Lee MS; Tseng IC; Zuo H; Barndt RJ; Johnson MD; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2006 Jul; 291(1):C40-9. PubMed ID: 16467405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
    Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
    J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
    Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
    Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.